Despite evidence-based guidelines recommending the use of beta blockers, statins, antiplatelets, and angiotensin-converting enzyme inhibitors in all cases of acute coronary syndrome, unless contraindicated [48, 49], a considerable number of patients did not receive these medications, despite their necessity in our study. This evidence concerns the gene ACE and acute coronary syndrome.